
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate

New Interact × Ragan Research Reveals Only 1% of Company Communicators Reach Frontline Workers Effectively

Former UK Transport Minister Steve Norris Joins the Board of Directors of Tellus Power Globe Holding Limited

Telnyx and Yeastar partner to empower businesses with complete control over their Unified Communications

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program


